Background Patients with genotype 1 hepatitis C virus (HCV) who do not have a sustained response to therapy with peginterferon alfa and ribavirin have a low likelihood of success with retreatment.
背景有基因1型丙型肝炎病毒（HCV）感染，但对聚乙二醇干扰素α和利巴韦林疗法没有持续应答的病人，复治成功的可能性低。
Background Patients with genotype 1 hepatitis C virus (HCV) who do not have a sustained response to therapy with peginterferon alfa and ribavirin have a low likelihood of success with retreatment.
背景有基因1型丙型肝炎病毒（HCV）感染，但对聚乙二醇干扰素α和利巴韦林疗法没有持续应答的病人，复治成功的可能性低。
应用推荐